Naproxen Orbit Pharma (Naproxen)

Naproxen works by reversibly blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for the production of prostaglandins. Lower prostaglandin levels reduce the sensitisation of pain receptors and diminish the inflammatory response, providing analgesic and anti‑inflammatory effects.

The appropriate dose of Naproxen Orbit Pharma is determined by the prescribing healthcare professional based on the specific indication, patient age, weight, renal and hepatic function, and overall risk profile. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Naproxen is generally classified as a pregnancy‑category drug that should be avoided, especially in the third trimester, due to potential risks to the fetus. It is also excreted in breast milk, so breastfeeding mothers should consult their physician before using naproxen.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Naproxen has a longer half‑life than many NSAIDs such as ibuprofen, allowing for less frequent dosing. It provides comparable analgesic and anti‑inflammatory efficacy but shares similar gastrointestinal and cardiovascular risk profiles. Choice of NSAID often depends on patient tolerance, dosing convenience, and specific risk factors.

Naproxen Orbit Pharma should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture, heat, and direct sunlight to maintain stability and potency.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. Patients should swallow the tablet whole and not crush or chew it unless directed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe renal impairment, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Naproxen should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulceration or bleeding, severe heart failure, uncontrolled hypertension, and in the third trimester of pregnancy. It is also contraindicated in patients with significant renal or hepatic impairment unless specifically directed by a physician.